Skip to main content

Table 3 Patterns of adoption and diffusion of TZD in 327 long-term hospitals

From: Diffusion patterns of new anti-diabetic drugs into hospitals in Taiwan: the case of Thiazolidinediones for diabetes

  

Initial time (month)

 

Peak Penetration1

 

Time to Peak (month)

 

Monthly growth (DDD/month)

 
 

N

mean

std

Mean

std

mean

std

mean

std

Total number

 

15.19

11.61

0.1166

0.0667

26.69

13.42

252.65

374.31

Accreditation level

         

   Medical Center

18

8.28

10.31

0.1034

0.0402

34.67

12.25

1275.25

692.43

   Regional Hospital

68

10.97

9.52

0.0985

0.0516

31.68

11.07

410.71

298.44

   District Hospital

241

16.90

11.77

0.1227

0.0711

24.69

13.57

131.67

176.87

Ownership

         

   Public Hospital

67

15.94

10.96

0.0782

0.0469

25.63

12.54

302.22

446.00

   Non-profit Hospital

65

12.22

10.18

0.1155

0.0543

31.40

12.45

467.35

513.15

   Private Hospital

195

15.93

12.15

0.1302

0.0712

25.49

13.74

164.04

238.14

BNHI Regions

         

   Taipei

78

13.12

9.96

0.1204

0.0657

28.19

13.10

314.77

475.98

   Northern

49

16.82

12.21

0.0818

0.0465

23.53

13.52

274.29

397.45

   Central

81

16.93

12.21

0.1333

0.0683

26.95

12.85

203.92

284.37

   Southern

49

14.08

11.22

0.1164

0.0689

22.90

11.79

294.41

374.88

   Kao-Ping

59

15.29

12.86

0.1189

0.0718

28.83

15.56

201.43

328.36

   Eastern

11

14.36

8.72

0.1104

0.0566

33.64

8.16

163.19

182.91

  1. 1: Peak Penetration among patients receiving non-insulin anti-diabetic agents